CELLIBRIUM BIOSCIENCES Trademark

Trademark Overview


On Friday, June 25, 2021, a trademark application was filed for CELLIBRIUM BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the CELLIBRIUM BIOSCIENCES trademark a serial number of 90795404. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Sunday, November 26, 2023. This trademark is owned by Cellibrium Biosciences, Inc.. The CELLIBRIUM BIOSCIENCES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of neurological diseases and neurodegenerative diseases; pharmaceutical preparations, namely, preparations for use in the treatment of Amyotrophic Lateral Sclerosis (ALS); pharmaceutical preparations, namely, B cell therapies for the treatment of neuroinflammation and immune dysregulation; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for the treatment of autoimmune diseases and traumatic brain injuries

Pharmaceutical research and development; Research and development services in the field of cell therapy
cellibrium biosciences

General Information


Serial Number90795404
Word MarkCELLIBRIUM BIOSCIENCES
Filing DateFriday, June 25, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateSunday, November 26, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of neurological diseases and neurodegenerative diseases; pharmaceutical preparations, namely, preparations for use in the treatment of Amyotrophic Lateral Sclerosis (ALS); pharmaceutical preparations, namely, B cell therapies for the treatment of neuroinflammation and immune dysregulation; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for the treatment of autoimmune diseases and traumatic brain injuries
Disclaimer with Predetermined Text"BIOSCIENCES"
Goods and ServicesPharmaceutical research and development; Research and development services in the field of cell therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 9, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 9, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCellibrium Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEast Walpole, MA 02032

Party NameCellibrium Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDedham, MA 02026

Trademark Events


Event DateEvent Description
Tuesday, November 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, November 26, 2023SOU EXTENSION 3 GRANTED
Sunday, November 26, 2023SOU EXTENSION 3 FILED
Sunday, November 26, 2023SOU TEAS EXTENSION RECEIVED
Friday, June 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 6, 2023SOU EXTENSION 2 GRANTED
Tuesday, June 6, 2023SOU EXTENSION 2 FILED
Tuesday, June 6, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 28, 2022SOU EXTENSION 1 GRANTED
Monday, November 28, 2022SOU EXTENSION 1 FILED
Monday, November 28, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, June 21, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 18, 2022EXAMINER'S AMENDMENT ENTERED
Friday, March 18, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 18, 2022EXAMINERS AMENDMENT E-MAILED
Friday, March 18, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, March 17, 2022ASSIGNED TO EXAMINER
Thursday, September 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 29, 2021NEW APPLICATION ENTERED